| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/24/2013 | CN101243087B 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them |
| 07/24/2013 | CN101212903B Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity |
| 07/24/2013 | CN101128199B Monocyclic heterocycles as kinase inhibitors |
| 07/23/2013 | US8492570 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor action |
| 07/23/2013 | US8492568 Chromane derivatives as TRPV3 modulators |
| 07/23/2013 | US8492563 4,5,6,7-tetrahydrobenzo[B]thiophene derivatives and their use as sigma receptor ligands |
| 07/23/2013 | US8492561 Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
| 07/23/2013 | US8492560 Quinazoline derivatives as angiogenesis inhibitors |
| 07/23/2013 | US8492557 Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol |
| 07/23/2013 | US8492555 Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1 H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester |
| 07/23/2013 | US8492554 Chemical compounds |
| 07/23/2013 | US8492553 Hepatitis C virus inhibitors |
| 07/23/2013 | US8492550 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 07/23/2013 | US8492548 Alkaloid aminoester derivatives and medicinal compositions thereof |
| 07/23/2013 | US8492547 Method for the enrichment of buprenorphine using chromatographic techniques |
| 07/23/2013 | US8492545 Aminothiazole compounds as kinase inhibitors and methods of using the same |
| 07/23/2013 | US8492544 Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}Methylcarbamate and its purification for use as pharmaceutically active compound |
| 07/23/2013 | US8492540 1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 07/23/2013 | US8492517 Melanocortin-1 receptor-specific cyclic peptides |
| 07/23/2013 | US8492488 Stabilized polymeric thiol reagents |
| 07/23/2013 | US8492443 Treatment for herpes simplex virus and other infectious diseases |
| 07/23/2013 | US8492442 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous activity |
| 07/23/2013 | US8492441 Dosage regimen of an S1P receptor agonist |
| 07/23/2013 | US8492440 Difluorophenyldiacylhydrazide derivatives |
| 07/23/2013 | US8492439 L-ornithine phenyl acetate and methods of making thereof |
| 07/23/2013 | US8492438 Treatment skin disorders |
| 07/23/2013 | US8492436 Inhibitors of yeast filamentous growth and method of their manufacture |
| 07/23/2013 | US8492435 Composition for treating a dermal anomaly |
| 07/23/2013 | US8492434 Antiviral drugs for treatment of arenavirus infection |
| 07/23/2013 | US8492433 Glycerol levulinate ketals and their use in the manufacture of polyurethanes, and polyurethanes formed therefrom |
| 07/23/2013 | US8492432 Mixture of antioxidants and mitochondrial cofactors; kidney disease or for improving kidney function. |
| 07/23/2013 | US8492431 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
| 07/23/2013 | US8492430 Fused cyclic compounds |
| 07/23/2013 | US8492429 Combination of IAP inhibitors and FLT3 inhibitors |
| 07/23/2013 | US8492428 Small-molecule botulinum toxin inhibitors |
| 07/23/2013 | US8492427 Isoindolones derivatives as MEK kinase inhibitors and methods of use |
| 07/23/2013 | US8492426 Use of carvedilol for treatment of diabetes mellitus |
| 07/23/2013 | US8492425 5-methyl-1-(naphthalen-2-yl)-1H-pyrazoles useful as sigma receptor inhibitors |
| 07/23/2013 | US8492424 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 07/23/2013 | US8492423 Pharmaceutical propylene glycol solvate compositions |
| 07/23/2013 | US8492422 Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions |
| 07/23/2013 | US8492421 Agent for fungal dermatitis |
| 07/23/2013 | US8492420 Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 07/23/2013 | US8492418 Method of treating schizophrenia prodrome |
| 07/23/2013 | US8492417 Topical use of thiazolidine derivatives against consequences of oxidative stress of skin |
| 07/23/2013 | US8492416 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/23/2013 | US8492415 Azoles and related derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) in antiviral therapy (HIV) |
| 07/23/2013 | US8492414 Antibacterial agents |
| 07/23/2013 | US8492413 Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer |
| 07/23/2013 | US8492412 Gel containing pirfenidone |
| 07/23/2013 | US8492411 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases |
| 07/23/2013 | US8492410 Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
| 07/23/2013 | US8492408 Benzimidazole derivatives and their use for modulating the GABAA receptor complex |
| 07/23/2013 | US8492407 Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| 07/23/2013 | US8492406 Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione |
| 07/23/2013 | US8492405 Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity |
| 07/23/2013 | US8492404 Bis-aryl amide compounds and methods of use |
| 07/23/2013 | US8492402 Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester |
| 07/23/2013 | US8492401 Thiazolopyridine sirtuin modulating compounds |
| 07/23/2013 | US8492400 Stable formulations, and methods of their preparation and use |
| 07/23/2013 | US8492398 Spiroazaindoles |
| 07/23/2013 | US8492397 Aminopyridine derivatives having Aurora A selective inhibitory action |
| 07/23/2013 | US8492396 Therapeutic uses of adrenergic α-1 receptor antagonists |
| 07/23/2013 | US8492395 7-substituted quinazolinone compounds and compositions comprising the same |
| 07/23/2013 | US8492394 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl-thiomorpholin-4-yl) derivatives of 6,7-dialkoxy-quinazoline, 6,7-dialkoxyphtalazine and 6,7-dialkoxyisoquinoline as PDE10A enzyme inhibitors |
| 07/23/2013 | US8492393 Heterobicyclic carboxamides as inhibitors for kinases |
| 07/23/2013 | US8492392 Alkoxy tetrahydro-pyridopyrimidine PDE10 inhibitors |
| 07/23/2013 | US8492391 Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives |
| 07/23/2013 | US8492389 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/23/2013 | US8492387 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/23/2013 | US8492386 Methods for treating HCV |
| 07/23/2013 | US8492385 Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof |
| 07/23/2013 | US8492384 Imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof |
| 07/23/2013 | US8492383 Combination of a nitrogen mustard analogue and imatinib for treatment of chronic lymphocytic leukemia |
| 07/23/2013 | US8492382 Method of treatment or prophylaxis |
| 07/23/2013 | US8492381 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway |
| 07/23/2013 | US8492379 Translocator protein ligands |
| 07/23/2013 | US8492378 GSK-3β inhibitor |
| 07/23/2013 | US8492377 MTKI quinazoline derivatives |
| 07/23/2013 | US8492376 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 07/23/2013 | US8492375 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists |
| 07/23/2013 | US8492374 Azaazulene compounds |
| 07/23/2013 | US8492373 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors |
| 07/23/2013 | US8492372 Modulators of dopamine neurotransmission |
| 07/23/2013 | US8492371 Compounds as cannabinoid receptor ligands |
| 07/23/2013 | US8492370 Compounds and methods for their production |
| 07/23/2013 | US8492369 Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
| 07/23/2013 | US8492368 Nasal delivery mechanism for prophylactic and post-acute use of progesterone and/or its enantiomer for use in treatment of mild traumatic brain injuries |
| 07/23/2013 | US8492367 Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea |
| 07/23/2013 | US8492366 E.g., salicylic acid, containing an alpha-hydroxy acid such as lactic, glycolic or citric acid |
| 07/23/2013 | US8492365 7-substituted tetracycline compounds |
| 07/23/2013 | US8492364 Methods and compositions relating to synthetic β-1,6 glucosamine oligosaccharides |
| 07/23/2013 | US8492363 Use of difructose anhydride-containing composition |
| 07/23/2013 | US8492362 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-varicella zoster virus agents and methods of use |
| 07/23/2013 | US8492361 Methods for treating non-small cell lung cancer using 5-azacytidine |
| 07/23/2013 | US8492360 Creamy O/W emulsion composition and production process thereof |
| 07/23/2013 | US8492355 Antisense modulation of apolipoprotein B expression |
| 07/23/2013 | US8492354 Antibacterial aminoglycoside analogs |
| 07/23/2013 | US8492353 Antiaging composition |
| 07/23/2013 | US8492352 Polysaccharides with antithrombotic activity, including a covalent bond and an amino chain |